Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut
Researchers at Michigan Medicine have successfully reversed a severe and often intractable form of fatty liver disease in animal studies by focusing on an unexpected entry point for hepatic damage:…
Experimental Drug Developed at Michigan Medicine Reverses Severe Fatty Liver Disease by Targeting the Gut
An experimental drug developed by researchers at Michigan Medicine has successfully reversed a severe and often intractable form of fatty liver disease in animal studies. Rather than focusing exclusively on…
Experimental Michigan Medicine Drug Reverses Severe Fatty Liver Disease by Targeting the Gut
Researchers at Michigan Medicine have successfully reversed a severe and complex form of fatty liver disease in animal studies by focusing on an unexpected therapeutic target: the gastrointestinal tract. The…
Experimental Drug CS18 Shows Promise in Overcoming Therapy-Resistant Tumors, Baylor Researchers Find
Researchers at the Baylor College of Medicine have developed an experimental small-molecule drug known as CS18 that offers a potential new avenue for tackling tumors that have grown resistant to…